{"organizations": [], "uuid": "7ea338b1ba9c1284f224817977df8c6a63d1d024", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180403.html", "section_title": "Archive News &amp; Video for Tuesday, 03 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-precipio-responses-to-articles-on/brief-precipio-responses-to-articles-on-its-approach-using-ice-cold-pcr-liquid-biopsy-tests-on-real-time-pcr-platforms-idUSFWN1RG0FN", "country": "US", "domain_rank": 408, "title": "BRIEF-Precipio - Responses To Articles, On Its Approach Using Ice Cold-Pcr Liquid Biopsy Tests On Real Time Pcr Platforms ‍​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.002, "site_type": "news", "published": "2018-04-03T20:03:00.000+03:00", "replies_count": 0, "uuid": "7ea338b1ba9c1284f224817977df8c6a63d1d024"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-precipio-responses-to-articles-on/brief-precipio-responses-to-articles-on-its-approach-using-ice-cold-pcr-liquid-biopsy-tests-on-real-time-pcr-platforms-idUSFWN1RG0FN", "ord_in_thread": 0, "title": "BRIEF-Precipio - Responses To Articles, On Its Approach Using Ice Cold-Pcr Liquid Biopsy Tests On Real Time Pcr Platforms ‍​", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "precipio inc", "sentiment": "negative"}, {"name": "time pcr platforms", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 3 (Reuters) - Precipio Inc:\n* PRECIPIO - RESPONSES TO ARTICLES, ON ITS APPROACH USING ICE COLD-PCR LIQUID BIOPSY TESTS ON REAL TIME PCR PLATFORMS ‍​ Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-03T20:03:00.000+03:00", "crawled": "2018-04-04T12:16:02.016+03:00", "highlightTitle": ""}